Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SPPL2B |
| Upstream (Parents) |
|---|
| (<<) AIFM1 → SPPL2B |
| (<<) CASP9 → SPPL2B |
| (<<) DVL1 → SPPL2B |
| (<<) ELF2 → SPPL2B |
| (<<) ENC1 → SPPL2B |
| (<<) MAP2K1 → SPPL2B |
| (<<) MAP2K3 → SPPL2B |
| (<<) MAP3K7 → SPPL2B |
| (<<) MAPK1 → SPPL2B |
| (<<) MKNK2 → SPPL2B |
| (<<) PIK3CB → SPPL2B |
| (<<) PIK3R5 → SPPL2B |
| (<<) PTGER1 → SPPL2B |
| (<<) SMARCC2 → SPPL2B |
| (<<) STK4 → SPPL2B |
| (<<) THRB → SPPL2B |
| (<<) YWHAQ → SPPL2B |
| Downstream (Children) |
|---|
| SPPL2B → ABCF1 (>>) |
| SPPL2B → APC2 (>>) |
| SPPL2B → CCDC88A (>>) |
| SPPL2B → CSF2 (>>) |
| SPPL2B → EGR1 (>>) |
| SPPL2B → EIF2AK2 (>>) |
| SPPL2B → EIF2C2 (>>) |
| SPPL2B → EPHA4 (>>) |
| SPPL2B → EWSR1 (>>) |
| SPPL2B → FGF7 (>>) |
| SPPL2B → FZD2 (>>) |
| SPPL2B → GNAI2 (>>) |
| SPPL2B → GNB1 (>>) |
| SPPL2B → GNE (>>) |
| SPPL2B → GRB10 (>>) |
| SPPL2B → GRB2 (>>) |
| SPPL2B → IQSEC2 (>>) |
| SPPL2B → JUN (>>) |
| SPPL2B → KHDRBS1 (>>) |
| SPPL2B → MAL (>>) |
| SPPL2B → MAP2K5 (>>) |
| SPPL2B → MAP3K12 (>>) |
| SPPL2B → MMP25 (>>) |
| SPPL2B → MRAS (>>) |
| SPPL2B → MYH14 (>>) |
| SPPL2B → MYL3 (>>) |
| SPPL2B → MYO10 (>>) |
| SPPL2B → NFAT5 (>>) |
| SPPL2B → NFKB2 (>>) |
| SPPL2B → PHOX2A (>>) |
| SPPL2B → PRKACB (>>) |
| SPPL2B → SERPINB2 (>>) |
| SPPL2B → SLC26A1 (>>) |
| SPPL2B → SMAD5 (>>) |
| SPPL2B → SOS2 (>>) |
| SPPL2B → STAT4 (>>) |
| SPPL2B → STK11 (>>) |
| SPPL2B → SYNJ2 (>>) |
| SPPL2B → TXNIP (>>) |
